Fig. 4From: Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasetsHeatmap of genes co-expressed with KPNA2 in healthy breast tissue (0) and ductal breast carcinoma (1). Selected parameters from Oncomine included a fold-change of 3, a P-value of 0.001, and gene rank within the top 10%). (source: Richardson Breast Study 2, N = 47 samples, and 19,574 measured genes) [33]Back to article page